⚡ This is your brand? Claim your page FREE and bring it to life on AI search.
Valkyrie Clinical Trials
AEO Score: 7/10
Monitoring for AI engine activity
In the Engagemii AEO index
What this score means
Your AEO score measures whether AI search engines (ChatGPT, Claude, Perplexity, Gemini) can actually read your site and cite it in answers. Two-thirds of websites are invisible to them. Valkyrie Clinical Trials just got measured.
7/10 means Valkyrie Clinical Trials is somewhat visible. AI bots can read you, but you are missing the structured signals that would push citation rate above competitors.
About Valkyrie Clinical Trials
Founded by Dr. David Berz, a leading medical oncologist, Valkyrie Clinical Trials, with a mission of providing access to the most effective cancer therapies.
Key Topics
Details
AI Visibility Breakdown
2
Structured Data
8
Content Structure
8
Entity Clarity
6
E-E-A-T Signals
8
Technical AEO
7
AI Discoverability
Is this your brand?
Claim free. You'll see:
Your full 6-category score breakdown
Exact fixes: robots.txt, schema, llms.txt
AI bot crawls from ChatGPT, Claude, Perplexity, Gemini
Personal 50% off code at checkout
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for Valkyrie Clinical Trials.
Source & Attribution
Scored by Engagemii on June 24, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/valkyrieclinicaltrials
Cite this score: Engagemii (2026). "AEO Score for Valkyrie Clinical Trials." Retrieved from https://engagemii.com/aeo/brands/valkyrieclinicaltrials
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform